CompletedPhase 3NCT02926170

Rivaroxaban for Patients With Antiphospholipid Syndrome

Studying Antiphospholipid syndrome

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Hospital Universitari Vall d'Hebron Research Institute
Principal Investigator
Josefina Cortes, MD,pHD
Vall d'Hebron Research Institute
Intervention
Rivaroxaban(drug)
Enrollment
190 enrolled
Eligibility
18-75 years · All sexes
Timeline
2013 – 2017

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02926170 on ClinicalTrials.gov

Other trials for Antiphospholipid syndrome

Additional recruiting or active studies for the same condition.

See all trials for Antiphospholipid syndrome →

← Back to all trials